Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

BIOR - Biora Therapeutics Inc


IEX Last Trade
0.6973
0.012   1.649%

Share volume: 81,309
Last Updated: Fri 30 Aug 2024 09:59:52 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$0.69
0.01
1.68%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31
Fiscal Quarter Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024
Report Date 2022-08-15 2022-11-14 2023-03-30 2023-05-15 2023-08-14 2023-11-13 2024-04-01 2024-05-15
Total revenue 104.000 K 80.000 K 14.000 K 2.000 K 2.000 K 0.000 0.000 542.000 K
Cost of revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 104.000 K 80.000 K 14.000 K 2.000 K 2.000 K 0.000 0.000 542.000 K
    -23.08% -82.50% -85.71% 0.00% -100.00% nan% inf%  
Operating expenses 14.314 M 13.967 M 13.790 M 15.546 M 14.936 M 23.321 M 13.344 M 16.058 M
Selling general and admin 8.410 M 8.147 M 8.023 M 8.356 M 8.953 M 12.774 M 7.226 M 9.053 M
Research and development 5.904 M 5.820 M 5.767 M 7.190 M 5.983 M 10.547 M 6.118 M 7.005 M
Total expenses 14.314 M 13.967 M 13.790 M 15.546 M 14.936 M 23.321 M 13.344 M 16.058 M
    -2.42% -1.27% 12.73% -3.92% 56.14% -42.78% 20.34%  
Operating income -14.210 M -13.887 M -13.776 M -15.544 M -14.934 M -23.321 M -13.344 M -15.516 M
Ebit -14.210 M -13.887 M -13.776 M -15.544 M -14.934 M -23.321 M -13.344 M -15.516 M
Pretax income -6.834 M -14.716 M -13.210 M -17.441 M -17.803 M -73.453 M -15.727 M -4.141 M
    115.34% -10.23% 32.03% 2.08% 312.59% -78.59% -73.67%  
Income tax -837.000 K 158.000 K 259.000 K 0.000 4.000 K 1.000 K -95.000 K 48.000 K
Net income basic -5.513 M -5.114 M -13.722 M -17.441 M -17.807 M -73.454 M -15.413 M -4.189 M
    7.24% -168.32% -27.10% -2.10% -312.50% 79.02% 72.82%  
Net income -5.513 M -5.114 M -13.722 M -17.441 M -17.807 M -73.454 M -15.413 M -4.189 M
    7.24% -168.32% -27.10% -2.10% -312.50% 79.02% 72.82%